Navigation Links
Corgenix Medical Corp. Announces Launch of Products for Automated Systems
Date:3/2/2010

DENVER, March 2 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced the availability of its new automation friendly anti-phospholipid assay format.

The new format offers high-volume testing labs the same performance as the currently available Corgenix rapid assay with improved efficiency and high-volume analysis.

"Offering both extended and short assay formats allows us to maintain our leadership position in anti-phospholipid antibody detection," said Douglass Simpson, Corgenix CEO and President. "Our customers can now compete more effectively with enhanced automated performance."

Automated microplate ELISA processing from Corgenix is available for a wide range of anti-phospholipid antibody screening tests, including anti-Cardiolipin (aCL) antibodies, anti-Phosphatidylserine (aPS) antibodies and anti-Beta2 Glycoprotein I IgG antibodies.

As the first company to obtain FDA clearance of its anti-Cardiolipin test, Corgenix maintains its commitment to offer the highest quality tests associated with SLE (lupus) and antiphospholipid syndrome, autoimmune mediated thrombotic diseases. It is estimated that over 3 million individuals in the United States and 10 million worldwide have lupus or lupus-like disorders.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network. More information is available at www.corgenix.com.

Statements in this press release that are not strictly historical facts are "forward-looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.

SOURCE Corgenix Medical Corporation

Back to top

RELATED LINKS
http://www.corgenix.com

'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Corgenix Reports Second Quarter Fiscal 2010 Financial Results
2. Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM)
3. Corgenix Reports Financial Results for First Quarter of Fiscal 2010
4. Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results
5. Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program
6. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
7. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
8. ATS Medical Announces Fourth Quarter and Full Year 2009 Results
9. First Perry Baromedical Sigma Elite Hyperbaric Chamber with EMR Installed at Stillwater Medical Center
10. Briggs Medical Service Company Receives ISO Registration and CE Mark Certification
11. APC Group, Inc. Reports Multi-Year Deal with Medical Device Manufacturer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... synthetic Fentanyl arrived on the streets in 2015, dealers were ... samples, inviting would-be customers to test a newly-created batch. They ... The rapidly-growing demand for the powerful ... has racked up a staggering death toll across ... fentanyl sales reveals that they have sold nearly 400 grams ...
(Date:1/16/2017)... , January 16, 2017 According to the new ... Multi Display , Smart Display, Graphic LCD Controller), Application (Industrial Control, ... published by MarketsandMakets, the market is expected to grow from USD 17.26 ... CAGR of 9.68% between 2016 and 2022. ... ...
(Date:1/16/2017)... Colo. , Jan. 16, 2017  Northern Colorado,s ... is bringing advanced laser treatments to Loveland ... clinic focuses solely on the removal of unwanted tattoos ... fading for tattoo cover-ups. "Tattoos are beautiful ... the way we hope they would," said Johnny ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... January 15, 2017 , ... Whole Health Supply, LLC is announcing the release of ... also new avenues for purchase. , The 2017 edition has wide jaws that will ... the older boomers as well as diabetics. This handle is reinforced for extra strength when ...
(Date:1/15/2017)... ... January 15, 2017 , ... San ... in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted and ... the award process. Results were announced the magazine’s January 2017 issue . ...
(Date:1/15/2017)... ... 2017 , ... The JPR Group, a public relations and ... will be assisting HackensackUMC Mountainside with its public relations efforts, effective January 2017. ... towns. The firm will be working closely with HackensackUMC Mountainside’s internal marketing operations. ...
(Date:1/14/2017)... ... , ... AgileMinder develops innovative products and services that bring "Care, Joy and ... Apple as a fun, free emoji sticker pack for iMessage. Use the stickers in ... coded values on The Emoji Scale. , On Apple: "The Emoji Scale by ...
(Date:1/13/2017)... Spain (PRWEB) , ... January 13, 2017 , ... The ... Melia Avenida America hotel on March 3-4, 2017. This Congress is expertly designed ... on the management of patients with lung cancer. , Chaired by Dr. Giorgio V. ...
Breaking Medicine News(10 mins):